Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
31 hedge funds and large institutions have $11.8M invested in Vicarious Surgical in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
3% more funds holding
Funds holding: 30 → 31 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.09% less ownership
Funds ownership: 34.23% → 34.14% (-0.09%)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
50% less capital invested
Capital invested by funds: $23.7M → $11.8M (-$11.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DP
DDD Partners
Bellevue,
Washington
|
+$335K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$179K |
| 3 |
DnB Asset Management
Oslo,
Norway
|
+$57.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$28.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAMHA
MY.Alpha Management HK Advisors
Hong Kong
|
-$289K |
| 2 |
Millennium Management
New York
|
-$238K |
| 3 |
JP Morgan Chase
New York
|
-$40.8K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.22K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.89K |
RBOT Hedge Fund Activity: Q1 2025 in Review
31 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q1 2025, worth a combined $11.8M — down 50% from $23.7M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RBOT positions and 2 closed out — a net gain of 1 holder — while 8 added to existing stakes and 10 trimmed.
The largest buyer was DDD Partners, adding an estimated $335K. The largest seller was MY.Alpha Management HK Advisors, cutting an estimated $289K.
- 31 institutional investors held Vicarious Surgical (RBOT) as of Q1 2025, up from 30 in Q4 2024.
- Funds reported $11.8M of Vicarious Surgical stock for Q1 2025, down 50% quarter-over-quarter.
- 3 funds opened new Vicarious Surgical positions in Q1 2025 and 2 closed out, a net change of +1 holder.
- The largest Vicarious Surgical buyer in Q1 2025 was DDD Partners, an estimated $335K added.
- The largest Vicarious Surgical seller in Q1 2025 was MY.Alpha Management HK Advisors, an estimated $289K sold.
Based on aggregated 13F filings for Q1 2025.